GST Benefits New Revised MRP, 100% GST benefit passed
Notify Me
Micro Labs Ltd

Voglinorm 0.2mg Tablet 10'S

Diabetes
MRP ₹130.50 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About VOGLINORM 0.2MG TABLET

    VOGLINORM 0.2MG TABLET is used in the management of type 2 diabetes mellitus along with diet and exercise to improve post-prandial blood glucose levels (when only diet and/or exercise or oral hypoglycemic drugs or insulin preparation in addition to diet and/or exercise does not result in adequate glycemic control). It contains Voglibose which belongs to the group of medicines called Anti-diabetics. It works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This manages the level of blood glucose from increasing very high immediately after meals.

    Along management with VOGLINORM 0.2MG TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. VOGLINORM 0.2MG TABLET is not recommended for use in patients having severe ketosis, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.

    VOGLINORM 0.2MG TABLET should be used with caution in patients undergoing abdominal laparotomy for gallstone ileus or have roemheld’s syndrome, stenosis, liver, and kidney problems and in elderly patients. VOGLINORM 0.2MG TABLET is not recommended for use among pregnant, breastfeeding women, children, and adolescents. The most common side effects of taking VOGLINORM 0.2MG TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your doctor if any of the above symptoms worsen.

    Uses Of VOGLINORM 0.2MG TABLET

    • Used to manage type 2 diabetes mellitus along with diet and exercise

    How VOGLINORM 0.2MG TABLET Works

    VOGLINORM 0.2MG TABLET works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This manages the level of blood glucose from increasing very high immediately after meals.

    How to use VOGLINORM 0.2MG TABLET

    • Take VOGLINORM 0.2MG TABLET as advised by your physician
    • For Tablet: Swallow the medicine with a glass of water. Do not crush or chew the medicine
    • For Mouth Dissolving Tablet: Let the tablet dissolve in your mouth. There is no need to chew or swallow it with water. It will typically dissolve within a few seconds to a minute.
    • Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition
    • Continue to take the medicine for the stipulated duration prescribed by your doctor to achieve better results

    Side Effects Of VOGLINORM 0.2MG TABLET

    Common side effects of VOGLINORM 0.2MG TABLET:

    • soft stools or diarrhea
    • flatulence, abdominal pain or discomfort

    Stop taking VOGLINORM 0.2MG TABLET and contact your physician immediately if you experience any of the following side effects:

    • signs of hypersensitivity reactions (severe skin rash with itching)

    Warning & Precautions

    Pregnancy

    Monitoring required

    VOGLINORM 0.2MG TABLET should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

    Breastfeeding

    Contraindicated

    VOGLINORM 0.2MG TABLET is not recommended for use in breastfeeding women as it may passes through breast milk.

    Kidney

    Use with Caution

    VOGLINORM 0.2MG TABLET should be taken with caution in patients with kidney problems.  

    Liver

    Use with Caution

    VOGLINORM 0.2MG TABLET should be taken with caution in patients with liver problems.

    Allergy

    Contraindicated

    Do not take VOGLINORM 0.2MG TABLET if you are allergic to Voglibose or any ingredients of this medicine.

    Use In Pediatrics

    Consult your doctor

    The safety of VOGLINORM 0.2MG TABLET in children has not been established.

    Use In Geriatrics

    Use with Caution

    VOGLINORM 0.2MG TABLET should be used with caution in elderly patients.

    Others

    VOGLINORM 0.2MG TABLET is not recommended for use if you have:

    • severe ketosis
    • severe infection, after and before an operation
    • serious trauma
    • gastrointestinal obstruction

    Before taking VOGLINORM 0.2MG TABLET, inform your physician if you:

    • are undergoing abdominal laparotomy for gallstone ileus
    • have roemheld’s syndrome (cluster of cardiovascular symptoms stimulated by gastrointestinal changes)
    • have stenosis (condition in which there is an abnormal narrowing in a blood vessel or other tubular organ or structure such as foramina and canals)

    Interactions

    A. Drug-Drug interactions:

    Before taking VOGLINORM 0.2MG TABLET, inform your physician if you are taking any of the following medicines:

    • Antidiabetics (Ex. glipizide, tolbutamide, insulin) (used to manage diabetes)
    • Beta blockers (Ex. metoprolol, atenolol)
    • Keratolytics (Ex. salicylic acid)
    • Monoamine oxidase inhibitors (MAOIs) (Ex. phenelzine, selegiline)
    • Anti-lipedmic agents (Ex. fenofibrate)
    • Sympathomimetics or adrenergic agonists (Ex. epinephrine)
    • Adrenocorticotropic hormones (Ex. adrenocorticotrophin)
    • Hormones (Ex. thyroxine)

    Overdosage:

    If you or anyone else accidentally takes too much of VOGLINORM 0.2MG TABLET, consult your physician immediately or visit the nearby hospital. Symptoms of overdosage are low blood sugar levels, abdominal discomfort and diarrhea.

    Synopsis

    Drug :   Voglibose
    Pharmacological Category :   Alpha Glucosidase inhibitors
    Therapeutic Indication :   Type 2 diabetes mellitus      
    Dosage Forms :   Tablet

    More Information

    FAQs About VOGLINORM 0.2MG TABLET

    Q: Can VOGLINORM 0.2MG TABLET cause diarrhea?

    A: Diarrhea is the common side-effect of VOGLINORM 0.2MG TABLET. Drink more fluids, such as water or fruit juice to keep yourself hydrated. Do not take any medicine on your own to manage diarrhea without consulting your physician.

    Q: Who should not take VOGLINORM 0.2MG TABLET?

    A: VOGLINORM 0.2MG TABLET is not recommended for use in patients having severe ketosis, in a state of diabetic coma, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.

    Q: What if I forget to take a dose of VOGLINORM 0.2MG TABLET?

    A: You should take VOGLINORM 0.2MG TABLET immediately when you remember. If it is time for your next dose skip missed the dose and follow your regular dose schedule. Do not double the dose to match up your missed dose.

    Q: How to take VOGLINORM 0.2MG TABLET?

    A: Take VOGLINORM 0.2MG TABLET as advised by your physician. Your physician will decide the correct dose and duration for you depending upon your age, body weight, and disease condition.

    Q: What are the common side effects of VOGLINORM 0.2MG TABLET?

    A: The most common side effects of taking VOGLINORM 0.2MG TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your physician if any of the symptoms worsen.

    Q: What happens when I take an overdose of VOGLINORM 0.2MG TABLET?

    A: If you or anyone else accidentally take too much of VOGLINORM 0.2MG TABLET, consult your physician immediately or visit the nearby hospital. The symptoms of overdosage are low blood sugar levels, abdominal discomfort, and diarrhea.

    References

    1. Alvin C. Powers and David D’Alessio. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 13th Edition. New York McGraw Hill Medical 2018. Page – 863-886.

    2. KD. Tripathi. Insulin, Oral Hypoglycemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page – 258-281.

    3. Ajay S. Dabhi, Nikita R. Bhatt, and Mohit J. Shah. Voglibose: An Alpha Glucosidase Inhibitor. Journal of Clinical and Diagnostic Research. December 2013 [Accessed on 21st June 2022] click here

    4. Sanjay Kalra, A Panneer Selvam, Amish V Shah, Kudugunti Neelaveni, Navneet Agrawal, Sambit Das, Vinay K Dhandhania, Subodh Jain, Pankaj Kumar Jha and Neha Rava. Prospective Multicenter Observational Study of Voglibose in Type 2 Diabetes-Victory. Journal of US Endocrinology. January 2020 [Accessed on 21st June 2022] click here

    5. Cipla Ltd. Prandal MD Tablets (Voglibose). Ciplamed. [Revised in August 2015] [Accessed on 21st June 2022] click here

    6. Amigoz life sciences. Voglibose Tablets. [Accessed on 21st June 2022] click here

    7. DM Pharma. Voglibose Tablet. Antidiabetic agents. [Accessed on 21st June 2022] click here

    Author Details

    Written By Srilekha. R - B.Pharm
    Reviewed For Accuracy By Dr. Jaya Prabakaran - MBBS, MD (Diabetology and Family Medicine)
    Last updated on 18 Nov 2024 | 03:27 PM(IST)
    Lab updated